Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab-Reference-Cited by-同舟云学术

Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab

Published:2020-10 Issue: Volume:45 Page:102442
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Iannetta Marco^ORCID,Cesta Novella,Stingone Christof,Malagnino Vincenzo,Teti Elisabetta,Vitale Pietro,De Simone Giuseppe,Rossi Benedetta,Ansaldo Lorenzo,Compagno Mirko,Spalliera Ilaria,Di Lorenzo Andrea,Landi Doriana^ORCID,Nicoletti Carolina Gabri,Marfia Girolama Alessandra,Andreoni Massimo,Sarmati Loredana

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference17 articles.

1. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells;Barr;J. Exp. Med.,2012

2. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod;Barzegar;Neurol. Neuroimmunol. Neuroinflamm.,2020

3. COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach;Borriello;Mult. Scler. Relat. Disord.,2020

4. Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia;Conte;Mult. Scler. Relat. Disord.,2020

5. Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod;Foerch;Mult. Scler. Relat. Disord.,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Features in Patients with Multiple Sclerosis: Main Approaches to Their Management, Treatment, and Vaccination;Annals of Clinical and Experimental Neurology;2023-06-21

2. The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study;Multiple Sclerosis and Related Disorders;2022-09

3. Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast;International Journal of Molecular Sciences;2022-07-30

4. B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications;Frontiers in Immunology;2022-01-17

5. Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies;Neurology;2021-11-22